• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cipher Pharmaceuticals Inc

+ Add to Watchlist


8.326 EUR 0.0000.00%

As of 09:34:21 ET on 09/18/2014.

Snapshot for Cipher Pharmaceuticals Inc (PHE)

Open: - Day's Range: - Volume: 0
Previous Close: 8.326 52wk Range: 4.338 - 8.510 1-Yr Rtn: +26.36%

Stock Chart for PHE

No chart data available.
  • PHE:GR 8.326
  • 1D
  • 1M
  • 1Y
Interactive PHE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PHE

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 17.1684
Relative P/E vs. DAX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (12/2014) 0.6850
Est. PEG Ratio -
Market Cap (M EUR) 211.66
Shares Outstanding (M) 25.42
30 Day Average Volume 13
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PHE

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for PHE

Cipher Pharmaceuticals Inc. is involved in the licensing, clinical development, and regulatory approval of prescription medications utilizing drug delivery technologies or new pharmaceuticals. The Company also conducts clinical trials, regulatory affairs services, and statistical analysis for the pharmaceutical, biotechnology, and medical devices industries.

Shawn Patrick O'BrienPresident/CEONorman EvansCFO/Secretary
Joan ChypyhaVP:Marketing & SalesJason D GrossVP:Scientific Affairs
More Company Profile & Key Executives for PHE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil